Normanno N - Search Results

1

Guidance for laboratories performing molecular pathology for cancer patients.

Cree IA, Deans Z, Ligtenberg MJ, Normanno N, Edsjö A, Rouleau E, Solé F, Thunnissen E, Timens W, Schuuring E, Dequeker E, Murray S, Dietel M, Groenen P, Van Krieken JH; European Society of Pathology Task Force on Quality Assurance in Molecular Pathology; Royal College of Pathologists. Cree IA, et al. Among authors: normanno n. J Clin Pathol. 2014 Nov;67(11):923-31. doi: 10.1136/jclinpath-2014-202404. Epub 2014 Jul 10. J Clin Pathol. 2014. PMID: 25012948 Free PMC article. Review.

2

Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma.

Normanno N, De Luca A, Salomon DS, Ciardiello F. Normanno N, et al. Cancer Detect Prev. 1998;22(1):62-7. Cancer Detect Prev. 1998. PMID: 9466051 Review.

3

EGF-related peptides in the pathophysiology of the mammary gland.

Normanno N, Ciardiello F. Normanno N, et al. J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):143-51. doi: 10.1023/a:1026351730785. J Mammary Gland Biol Neoplasia. 1997. PMID: 10882300 Review.

4

Role of the cripto (EGF-CFC) family in embryogenesis and cancer.

Bianco C, Normanno N, Salomon DS, Ciardiello F. Bianco C, et al. Among authors: normanno n. Growth Factors. 2004 Sep;22(3):133-9. doi: 10.1080/08977190410001723290. Growth Factors. 2004. PMID: 15518236 Review. No abstract available.

5

Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.

Di Maio M, Gridelli C, Normanno N, Perrone F, Ciardiello F. Di Maio M, et al. Among authors: normanno n. J Cell Physiol. 2005 Dec;205(3):355-63. doi: 10.1002/jcp.20402. J Cell Physiol. 2005. PMID: 15895392 Review.

6

A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells.

Bevilacqua S, Gallo M, Franco R, Rossi A, De Luca A, Rocco G, Botti G, Gridelli C, Normanno N. Bevilacqua S, et al. Among authors: normanno n. Lung Cancer. 2009 Jul;65(1):123-5. doi: 10.1016/j.lungcan.2009.01.019. Epub 2009 Mar 3. Lung Cancer. 2009. PMID: 19261349

7

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

Normanno N, Tejpar S, Morgillo F, De Luca A, Van Cutsem E, Ciardiello F. Normanno N, et al. Nat Rev Clin Oncol. 2009 Sep;6(9):519-27. doi: 10.1038/nrclinonc.2009.111. Epub 2009 Jul 28. Nat Rev Clin Oncol. 2009. PMID: 19636327 Review.

8

Re: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.

Normanno N, Tejpar S, Ciardiello F. Normanno N, et al. J Natl Cancer Inst. 2010 Apr 21;102(8):573; author reply 573-5. doi: 10.1093/jnci/djq064. Epub 2010 Mar 19. J Natl Cancer Inst. 2010. PMID: 20305131 No abstract available.

9

Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.

Carotenuto P, Roma C, Rachiglio AM, Tatangelo F, Pinto C, Ciardiello F, Nappi O, Iaffaioli RV, Botti G, Normanno N. Carotenuto P, et al. Among authors: normanno n. Pharmacogenomics. 2010 Aug;11(8):1169-79. doi: 10.2217/pgs.10.86. Pharmacogenomics. 2010. PMID: 20712532 Clinical Trial.

10

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

De Roock W, De Vriendt V, Normanno N, Ciardiello F, Tejpar S. De Roock W, et al. Among authors: normanno n. Lancet Oncol. 2011 Jun;12(6):594-603. doi: 10.1016/S1470-2045(10)70209-6. Epub 2010 Dec 14. Lancet Oncol. 2011. PMID: 21163703 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

363 results

Search Page